Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?

Xoma (XOMA Quick QuoteXOMA - Free Report) shares rallied 6.4% in the last trading session to close at $28.72.

Zacks Jul 18 03:25 ET

FDA Convenes Expert Panel Meeting For Zevra Therapeutics' Arimoclomol, Analyst Optimistic About Approval Despite Small Patient Base

The FDA will convene a meeting with the recently formed Genetic Metabolic Diseases Advisory Committee (GeMDAC) on August 2 to review the marketing application for Zevra Therapeutics Inc.'s (NASDAQ:

BenzingaJul 9 15:27 ET

Demystifying XOMA: Insights From 5 Analyst Reviews

In the preceding three months, 5 analysts have released ratings for XOMA (NASDAQ:XOMA), presenting a wide array of perspectives from bullish to bearish.The table below summarizes their recent ratings,

BenzingaJul 9 10:01 ET

Express News | XOMA Corp - Filed Amendment to Amended Certificate of Incorporation to Change Name of Co From "XOMA Corporation" to "XOMA Royalty Corporation"

ReutersJul 9 08:08 ET

XOMA Price Target Maintained With a $74.00/Share by HC Wainwright & Co.

XOMA Price Target Maintained With a $74.00/Share by HC Wainwright & Co.

Dow JonesJul 9 06:38 ET

H.C. Wainwright Maintains XOMA Corp(XOMA.US) With Buy Rating, Maintains Target Price $74

H.C. Wainwright analyst Joseph Pantginis maintains $XOMA Corp(XOMA.US)$ with a buy rating, and maintains the target price at $74.According to TipRanks data, the analyst has a success rate of 33.1%

Moomoo NewsJul 9 06:31 ET · Ratings